+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Skin Cancer Dermatology Market by Cancer Type (Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma), Treatment Modality (Photodynamic Therapy, Radiotherapy, Surgical Procedures), Therapeutic Class, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Skin Cancer Dermatology Market by Cancer Type (Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma), Treatment Modality (Photodynamic Therapy, Radiotherapy, Surgical Procedures), Therapeutic Class, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Skin Cancer Dermatology Market by Cancer Type (Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma), Treatment Modality (Photodynamic Therapy, Radiotherapy, Surgical Procedures), Therapeutic Class, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011764
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Skin Cancer Dermatology Market is evolving rapidly as organizations integrate novel technologies, personalized medicine, and collaborative care strategies to improve early detection and outcomes while adapting to new regulatory and economic dynamics. Demand for advanced dermatological oncology solutions is driving innovation and operational shifts as healthcare systems respond to complex patient needs, changing policy frameworks, and emerging global challenges.

Market Snapshot: Skin Cancer Dermatology Market

The Skin Cancer Dermatology Market grew from USD 8.42 billion in 2024 to USD 9.03 billion in 2025, and is projected to expand at a CAGR of 7.28%, reaching USD 12.84 billion by 2030. Skin cancer dermatology continues to develop as care models shift toward multidisciplinary collaboration, robust patient engagement initiatives, and digital transformation. Market momentum is reinforced by continuous advances in diagnostic accuracy, therapeutic innovations, and adaptive policy responses across major healthcare regions.

Scope & Segmentation

Senior decision-makers evaluating this market can leverage comprehensive segmentation covering cancer types, treatments, technologies, end users, distribution channels, regional dynamics, and leading company strategies.

  • Cancer Types: Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma.
  • Treatment Modalities: Photodynamic Therapy, Radiotherapy, Surgical Procedures (Cryosurgery, Curettage and Electrodesiccation, Excisional Surgery, Mohs Surgery), Topical Medications.
  • Therapeutic Classes: Chemotherapy Agents, Immunotherapies (Checkpoint Inhibitors, Cytokine Therapies, Oncolytic Viruses), Photodynamic Agents, Targeted Therapies.
  • End Users: Ambulatory Surgical Centers, Dermatology Clinics, Hospitals.
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Merck & Co., Inc., Bristol-Myers Squibb Company, Roche Holding AG, Novartis AG, Amgen Inc., AstraZeneca PLC, Pfizer Inc., Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline plc.

Key Takeaways for Strategic Decision-Makers

  • Adoption of artificial intelligence-driven diagnostics is accelerating, enhancing lesion recognition and enabling more precise treatment decisions across varied clinical settings.
  • Demand for multidisciplinary and patient-centric care models is growing, with digital platforms such as teledermatology supporting faster specialist access and improved care coordination.
  • Therapeutic innovation is shifting focus beyond traditional interventions to combination regimens, including immunotherapies and targeted agents, particularly in addressing advanced and treatment-resistant cancer subtypes.
  • Value-based reimbursement structures and real-world evidence requirements are prompting organizations to substantiate therapeutic value with clinical and economic outcomes.
  • Regional market dynamics necessitate tailored strategies, as regulatory complexity and infrastructure readiness differ widely across geographies, impacting technology adoption rates and access.
  • Intensified competition among leading pharmaceutical and biotechnology firms drives collaborative research, digital integration, and agile supply chain management to capture new market opportunities.

Tariff Impact: Evolving U.S. Tariff Policies

Recent United States tariff changes have increased costs for imported active pharmaceutical ingredients and diagnostic equipment, affecting dermatological supply chains and cross-border collaborations. Companies are mitigating these challenges by diversifying suppliers, localizing manufacturing, and refining supply chain strategies to maintain business continuity and operational resilience.

Methodology & Data Sources

Findings in this report are based on a blend of primary research—such as interviews with clinical, regulatory, and supply chain stakeholders—and secondary analysis of scientific literature, regulatory filings, and external market databases. Analytical tools employed include SWOT analysis, scenario planning, and expert panel validation to ensure the reliability and depth of insights.

Why This Report Matters

  • Provides a comprehensive framework for evaluating the skin cancer dermatology market’s risk, opportunity, and innovation landscape to support data-driven strategy decisions.
  • Equips executives with actionable intelligence on emerging care models, evolving regulatory standards, and technology adoption, enhancing readiness for shifting market conditions.

Conclusion

With ongoing advances across technologies, therapies, and care models, the Skin Cancer Dermatology Market offers significant competitive opportunities for leaders prepared to innovate, collaborate, and adapt to regulatory and economic change. Strategic foresight and operational agility are key to driving improved outcomes and sustainable business growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing utilization of artificial intelligence imaging solutions for precise melanoma diagnosis and prognosis
5.2. Growing investment in personalized immunotherapy treatments targeting advanced-stage melanoma lesions
5.3. Expansion of teledermatology platforms facilitating remote skin cancer screening and patient triage
5.4. Introduction of novel topical therapies incorporating checkpoint inhibitors for localized non-melanoma skin cancers
5.5. Increasing regulatory approvals for combination therapy regimens in metastatic melanoma treatment landscapes
5.6. Rising demand for handheld multispectral imaging devices enabling early detection of basal cell carcinoma lesions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Skin Cancer Dermatology Market, by Cancer Type
8.1. Introduction
8.2. Basal Cell Carcinoma
8.3. Melanoma
8.4. Squamous Cell Carcinoma
9. Skin Cancer Dermatology Market, by Treatment Modality
9.1. Introduction
9.2. Photodynamic Therapy
9.3. Radiotherapy
9.4. Surgical Procedures
9.4.1. Cryosurgery
9.4.2. Curettage And Electrodesiccation
9.4.3. Excisional Surgery
9.4.4. Mohs Surgery
9.5. Topical Medications
10. Skin Cancer Dermatology Market, by Therapeutic Class
10.1. Introduction
10.2. Chemotherapy Agents
10.3. Immunotherapies
10.3.1. Checkpoint Inhibitors
10.3.2. Cytokine Therapies
10.3.3. Oncolytic Viruses
10.4. Photodynamic Agents
10.5. Targeted Therapies
11. Skin Cancer Dermatology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Dermatology Clinics
11.4. Hospitals
12. Skin Cancer Dermatology Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Skin Cancer Dermatology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Skin Cancer Dermatology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Skin Cancer Dermatology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Bristol-Myers Squibb Company
16.3.3. Roche Holding AG
16.3.4. Novartis AG
16.3.5. Amgen Inc.
16.3.6. AstraZeneca PLC
16.3.7. Pfizer Inc.
16.3.8. Sanofi S.A.
16.3.9. Eli Lilly and Company
16.3.10. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SKIN CANCER DERMATOLOGY MARKET: RESEARCHAI
FIGURE 26. SKIN CANCER DERMATOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 27. SKIN CANCER DERMATOLOGY MARKET: RESEARCHCONTACTS
FIGURE 28. SKIN CANCER DERMATOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY BASAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY BASAL CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CRYOSURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CRYOSURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CURETTAGE AND ELECTRODESICCATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CURETTAGE AND ELECTRODESICCATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY EXCISIONAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY EXCISIONAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MOHS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MOHS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TOPICAL MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TOPICAL MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHEMOTHERAPY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHEMOTHERAPY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CYTOKINE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CYTOKINE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONCOLYTIC VIRUSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONCOLYTIC VIRUSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 106. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 107. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 108. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 109. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 110. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 111. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 112. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 113. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 122. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 123. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 190. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 191. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 192. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 193. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 194. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 195. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 196. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 197. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 198. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 199. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 204. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 205. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 206. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 207. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 208. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 209. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 210. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 211. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 212. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 213. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 232. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 233. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 234. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 235. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 236. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 237. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 238. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 239. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 240. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 241. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 246. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 247. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 248. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 249. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 250. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 251. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 252. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 253. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 254. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 255. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 302. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 303. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 304. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 305. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 306. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 307. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 308. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 309. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2024 (USD MILLION)
TABLE 310. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2025-2030 (USD MILLION)
TABLE 311. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Roche Holding AG
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Eli Lilly and Company
  • GlaxoSmithKline plc

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.84 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Skin Cancer Diagnostics & Therapeutics Market by Therapeutic Approach (Cryotherapy, Immunotherapy, Photodynamic Therapy), Cancer Type (Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma), Diagnostic Type, End User - Global Forecast 2025-2030 - Product Image

Skin Cancer Diagnostics & Therapeutics Market by Therapeutic Approach (Cryotherapy, Immunotherapy, Photodynamic Therapy), Cancer Type (Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma), Diagnostic Type, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Prescription Dermatology Therapeutics - Global Strategic Business Report - Product Image

Prescription Dermatology Therapeutics - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Actinic Keratosis Treatment - Global Strategic Business Report - Product Image

Actinic Keratosis Treatment - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Ozone Therapy in Dermatology Market by Product (Accessories, Ozonated Oils & Creams, Ozone Chambers/Bags), Treatment Method (Ozone Water Therapy, Systemic Ozone Therapy, Topical Ozone Therapy), Application, Distribution Channel, End-User - Global Forecast 2025-2030 - Product Image

Ozone Therapy in Dermatology Market by Product (Accessories, Ozonated Oils & Creams, Ozone Chambers/Bags), Treatment Method (Ozone Water Therapy, Systemic Ozone Therapy, Topical Ozone Therapy), Application, Distribution Channel, End-User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 247 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.